The University of Chicago Header Logo

Connection

Vesselin Dimov to Asthma

Back to Details
This is a "connection" page, showing publications Vesselin Dimov has written about Asthma.
Vesselin Dimov
Connection Strength
0.697
Asthma
  1. Pharmacokinetic drug evaluation of mepolizumab for the treatment of severe asthma associated with persistent eosinophilic inflammation in adults. Expert Opin Drug Metab Toxicol. 2017 Dec; 13(12):1275-1280.
    View in: PubMed
    Score: 0.306
  2. Innovations in technology: social media and mobile technology in the care of adolescents with asthma. Curr Allergy Asthma Rep. 2012 Dec; 12(6):607-12.
    View in: PubMed
    Score: 0.216
  3. Immunomodulators in asthma therapy. Curr Allergy Asthma Rep. 2009 Nov; 9(6):475-83.
    View in: PubMed
    Score: 0.175
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.